Increased Prostaglandin Activity [PE] - N0000009526

Pharmacologic Class Information

Pharmacologic Code N0000009526
Pharmacologic Name Increased Prostaglandin Activity
Pharmacologic Uses
  • prostaglandin analog
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased Prostaglandin Activity

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Increased Prostaglandin Activity [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0781-6184Tafluprost Non-Proprietary Name: TafluprostSolution/ DropsOphthalmicSandoz IncACTIVE
17478-609Zioptan Non-Proprietary Name: TafluprostSolution/ DropsOphthalmicAkornACTIVE
42571-264Tafluprost Non-Proprietary Name: Tafluprost OpthalmicSolution/ DropsOphthalmicMicro Labs LimitedACTIVE
65302-062Tafluprost Non-Proprietary Name: TafluprostSolutionOphthalmicThe Ritedose CorporationACTIVE
66993-429Tafluprost Ophthalmic Non-Proprietary Name: TafluprostSolution/ DropsOphthalmicPrasco LaboratoriesACTIVE
82584-609Zioptan Non-Proprietary Name: TafluprostSolution/ DropsOphthalmicThea Pharma Inc.ACTIVE